OPTICATH CENTRAL VENOUS OXIMETRY PROBE WITH FLUIDIC SEAL WITH/WITHOUT HEPARIN— 510(k) K061159

Substantially Equivalent

Hospira, Inc.

FDA 510(k) clearance K061159 for OPTICATH CENTRAL VENOUS OXIMETRY PROBE WITH FLUIDIC SEAL WITH/WITHOUT HEPARIN, Substantially Equivalent on 2006-06-26. Applicant: Hospira, Inc..

Clearance details

Applicant: Hospira, Inc.
Product code: Code DQE
Advisory panel: Cardiovascular
Date received: 2006-04-26
Decision date: 2006-06-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Lake Forest, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.